A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Amanda E. Nelson et al.|Nature Medicine|2018Cited by 1k
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J. Combes, Sima P. Porten, Bushra Samad et al.|Cell|2021Cited by 172
Cytomegalovirus Infection Drives Avidity Selection of Natural Killer CellsNicholas M. Adams, Joseph C. Sun, Clair D. Geary et al.|Immunity|2019Cited by 58